Fig. 2: Kaplan–Meier analyses of disease-free survival (DFS) and overall survival (OS) according to different NLR statuses of the TIME in patients with gastric cancer.

a Disease-free survival according to different NLR statuses of the TIME in the training cohort, internal validation cohort 1, and external validation cohort 1. b Overall survival according to different NLR statuses of the TIME in the training cohort, internal validation cohort 1, and external validation cohort 1. NLR-L: NLR-Low group, NLR-M: NLR-Mix group, NLR-H: NLR-High group, comparisons of the above progression survival curves were performed with a two-sided log-rank test. Dashed lines around the survival curves represent 95% confidence intervals. Source data are provided as a Source data file.